All bills
HR 796In Committee

Second Chance for Moms Act

Introduced January 28, 2025

Summary

Second Chance for Moms Act of 2025This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

Timeline

  1. Referred to the House Committee on Energy and Commerce.

  2. Introduced in House

  3. Introduced in House

See how this bill affects you

Enter your details to get a personalized impact estimate.

Check your impact